Cargando…

Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy

Patient. A 65-year old man who had previously undergone surgery for benign prostatic hyperplasia presented with symptoms of recurrent bladder outflow obstruction. Cystoscopy revealed the presence of recurrent tissue. Results. Histology identified a leiomyosarcoma. Several years after further surgery...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Sharkawi, Salah, Vaughton, Keith
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373583/
https://www.ncbi.nlm.nih.gov/pubmed/18521202
http://dx.doi.org/10.1080/13577149778498
_version_ 1782154380523339776
author El-Sharkawi, Salah
Vaughton, Keith
author_facet El-Sharkawi, Salah
Vaughton, Keith
author_sort El-Sharkawi, Salah
collection PubMed
description Patient. A 65-year old man who had previously undergone surgery for benign prostatic hyperplasia presented with symptoms of recurrent bladder outflow obstruction. Cystoscopy revealed the presence of recurrent tissue. Results. Histology identified a leiomyosarcoma. Several years after further surgery and radiotherapy, the patient presented with secondaries in the lungs and brain, but there was no evidence of local recurrence. Discussion. It is suggested that combined modality therapy (conservative surgical resection followed by adjuvant radical radiotherapy) be the initial treatment for prostatic leiomyosarcoma.
format Text
id pubmed-2373583
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23735832008-06-02 Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy El-Sharkawi, Salah Vaughton, Keith Sarcoma Research Article Patient. A 65-year old man who had previously undergone surgery for benign prostatic hyperplasia presented with symptoms of recurrent bladder outflow obstruction. Cystoscopy revealed the presence of recurrent tissue. Results. Histology identified a leiomyosarcoma. Several years after further surgery and radiotherapy, the patient presented with secondaries in the lungs and brain, but there was no evidence of local recurrence. Discussion. It is suggested that combined modality therapy (conservative surgical resection followed by adjuvant radical radiotherapy) be the initial treatment for prostatic leiomyosarcoma. Hindawi Publishing Corporation 1997-03 /pmc/articles/PMC2373583/ /pubmed/18521202 http://dx.doi.org/10.1080/13577149778498 Text en Copyright © 1997 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
El-Sharkawi, Salah
Vaughton, Keith
Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy
title Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy
title_full Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy
title_fullStr Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy
title_full_unstemmed Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy
title_short Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy
title_sort prostatic leiomyosarcoma: the case for combined modality therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373583/
https://www.ncbi.nlm.nih.gov/pubmed/18521202
http://dx.doi.org/10.1080/13577149778498
work_keys_str_mv AT elsharkawisalah prostaticleiomyosarcomathecaseforcombinedmodalitytherapy
AT vaughtonkeith prostaticleiomyosarcomathecaseforcombinedmodalitytherapy